IRADIMED CORPORATION Announces First Quarter 2021 Financial Results
April 30, 2021 07:00 ET
|
iRadimed Corporation
Reports first quarter 2021 revenue of $9.2 million, GAAP diluted EPS of $0.11 and non-GAAP diluted EPS of $0.13Reports combined cash and investments of $52.7 million as of March 31, 2021 WINTER...
IRADIMED CORPORATION to Hold 2021 First Quarter Financial Results Conference Call on April 30th
April 09, 2021 07:00 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., April 09, 2021 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2021 first quarter financial results before the market...
IRADIMED CORPORATION Announces Fourth Quarter 2020 Financial Results
February 04, 2021 07:00 ET
|
iRadimed Corporation
Reports fourth quarter 2020 revenue of $8.5 million, GAAP diluted EPS of $0.05 and non-GAAP diluted EPS of $0.07Reports combined cash and investments of $52.0 million as of December 31, 2020 WINTER...
IRADIMED CORPORATION to Hold 2020 Fourth Quarter Financial Results Conference Call on February 4th
January 27, 2021 07:00 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., Jan. 27, 2021 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2020 fourth quarter financial results before the market...
IRADIMED CORPORATION Announces Third Quarter 2020 Financial Results
October 30, 2020 07:00 ET
|
iRadimed Corporation
Reports third quarter 2020 revenue of $7.7 million, GAAP diluted EPS of $0.09 and non-GAAP diluted EPS of $0.11Reports combined cash and investments of $49.9 million as of September 30, 2020 WINTER...
IRADIMED CORPORATION to Hold 2020 Third Quarter Financial Results Conference Call on October 30th
October 08, 2020 07:00 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., Oct. 08, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2020 third quarter financial results before the market...
IRADIMED CORPORATION Announces Second Quarter 2020 Financial Results
July 30, 2020 07:00 ET
|
iRadimed Corporation
Reports second quarter 2020 revenue of $6.8 million, GAAP diluted EPS of $(0.17) and non-GAAP diluted EPS of $0.05Reports combined cash and investments of $47.8 million as of June 30, 2020 WINTER...
IRADIMED CORPORATION to Hold 2020 Second Quarter Financial Results Conference Call on July 30th
July 16, 2020 07:00 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., July 16, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2020 second quarter financial results before the market...
IRADIMED CORPORATION Names Roger Susi as President and Chief Executive Officer
May 29, 2020 07:00 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., May 29, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), announced today that its Board of Directors has appointed Roger Susi to resume his duties as the Company’s...
IRADIMED CORPORATION Announces Issuance of U.S. Patent
May 11, 2020 07:00 ET
|
iRadimed Corporation
WINTER SPRINGS, Fla., May 11, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced the issuance by the U.S. Patent and Trademark Office of a patent that expands on previous...